Profiel
David Browning is currently the Chairman at OBN (UK) Ltd.
He previously held the position of Chief Executive Officer at Fixed-Phage Ltd.
and Oxford Cancer Biomarkers Ltd.
Actieve functies van David Browning
| Bedrijven | Functie | Begin |
|---|---|---|
OBN (UK) Ltd.
 OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Voorzitter | 01-09-2020 |
Eerdere bekende functies van David Browning
| Bedrijven | Functie | Einde |
|---|---|---|
Fixed-Phage Ltd.
 Fixed-Phage Ltd. Medical/Nursing ServicesHealth Services Fixed-Phage Ltd. provides research for treatment and prevention of infection and bacterial contamination. The firm is engaged in developing and commercializing bacteriophage immobilization and stabilization technology. The company was founded by Mike Mattey and is headquartered in Glasgow, the United Kingdom. | Algemeen Directeur | 24-05-2023 |
Oxford Cancer Biomarkers Ltd.
 Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Oxford Cancer Biomarkers Ltd.
Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom. | Health Services |
OBN (UK) Ltd.
OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Commercial Services |
Fixed-Phage Ltd.
Fixed-Phage Ltd. Medical/Nursing ServicesHealth Services Fixed-Phage Ltd. provides research for treatment and prevention of infection and bacterial contamination. The firm is engaged in developing and commercializing bacteriophage immobilization and stabilization technology. The company was founded by Mike Mattey and is headquartered in Glasgow, the United Kingdom. | Health Services |
